Barack Obama and John Edwards have adopted a risky campaign strategy: Portray Hillary Clinton as no different from President Bush. Yes, it's official: They have gone negative.
Likening Clinton (D., N.Y.) to Bush -- in particular criticizing her for secrecy about her years as first lady -- is a stretch that could backfire. For starters, Democratic voters might not buy the idea that Clinton shares qualities with Bush. This approach also reinforces Republican talking points, which would be a tactical error. Moreover, if the past is a guide to the future, both Edwards (D., N.C.) and Obama (D., Ill.) had better clear up questions about their own pasts before railing on Clinton's. Clinton admitted yesterday that her most recent debate performance wasn't "her best." But a USA Today/Gallup poll released today shows it hasn't affected her position in the race. After the debate, Obama announced his concerns about Clinton:After the most secretive administration in memory, an administration that consistently misled the American people, we need a president who is going to be open and forthright. ... Her big answer on whether she would release the papers from her White House years was particularly troubling because she is running on her record as first lady as much as on her record as a senator.I assume Obama is referring to incidents like the Bush administration's attempt to hide the involvement of big oil companies with Vice President Dick Cheney's energy task force in 2001. Exxon Mobil(XOM), Conoco(COP), Shell(RDS.A) and BP(BP) all denied taking part in it, but four years later documents demonstrated they had. The administration used executive privilege to shield them from revealing the information. I would think that if Clinton's history is meaningful, then so is Obama's. I pointed out in a previous article that Obama has had conflicts with the energy industry, as was evident when he voted for a pork-laden 2005 Energy bill. He similarly worked with lobbyists to help two foreign firms with offices in his district: NuFarm, an Australian chemical company, and Astellas Pharma, a Japanese drug company.
- Loading Comments...
- Loading Comments...
Recent Comments
Featured Photo Galleries
-
Sanofi Nearer to Genyzme Bid
The Wall Street Journal.
-
Fed's Beige Book: Activity continued to increase, "steady" in some districts
Calculated Risk
-
Amazon Doubles Down on the Kindle
BusinessWeek Online
-
Russia Moves to Sell Shares in State Companies
New York Times
-
Fixed retirement age to be axed
BBC
-
On midterm campaign trail, Obama mixes populist appeal with wooing of big donors
Washington Post
-
Behind Disney's Digital Shopping Spree
BusinessWeek Online
-
Blinder and Zandi Paper
Calculated Risk
-
Europe's Two-Speed Economy: North Vs. South
New York Times
-
Adobe to Launch Tender Offer for Day Software
The Wall Street Journal.
TheStreet Premium Services
Jim Cramer's Action Alerts PLUS: Now any level of investor can trade right alongside a Wall Street pro — and enjoy 24/7 access to his portfolio! Learn More
RealMoney Silver: Get Doug Kass's exclusive trading diary + 5 of TheStreet's top premium services including Action Alerts PLUS and RealMoney — all on one streamlined page. Learn More
Stocks Under $10: Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn More
OptionsProfits: Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn More
Breakout Stocks: Find tomorrow's household names today. Bryan Ashenberg finds hidden gems in exciting up-and-coming markets that he believes are ready to break out! Learn More
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,497.88 | 1,106.13 | 2,264.56 | 30.01 |
Oil *
75.81
|
|
DOWN
39.81 |
DOWN
7.71 |
DOWN
23.69 |
DOWN
0.46 |
10 Yr
3.00%
SPDR Gold
113.78
|
|
-0.38%
|
-0.69%
|
-1.04%
|
-1.51%
|
Data delayed 20 minutes |

Connect with TheStreet